Negrier S, Bonastre J, Colrat F, Teitsson S, et al. Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in France. World J Urol 2025;43:202.
PMID: 40167779